Tri-therapy (SPINALON)-Elicited Spinal Locomotor Network Activation: Phase I-IIa Clinical Trial in Patients With Chronic Spinal Cord Injury

Trial Profile

Tri-therapy (SPINALON)-Elicited Spinal Locomotor Network Activation: Phase I-IIa Clinical Trial in Patients With Chronic Spinal Cord Injury

Completed
Phase of Trial: Phase I/II

Latest Information Update: 28 Jan 2016

At a glance

  • Drugs Buspirone/carbidopa/levodopa (Primary)
  • Indications Spinal cord injuries
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Nordic life science pipeline
  • Most Recent Events

    • 28 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top